|
Rosuvastatin Clinical Trials
3 actively recruiting trials across 2 locations
▼ -1 trial since June 2026
Also known as: Rosuvastatin 10 mg, Rosuvastatin 20 mg
Pipeline
Phase 2: 1Phase 4: 2
Top Sponsors
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
- Nanjing First Hospital, Nanjing Medical University1
- Brigham and Women's Hospital1
Indications
- Cirrhosis Alcoholic1
- Cirrhosis Infectious1
- Cirrhosis Advanced1
- Cirrhosis Early1
- Cardiovascular Events1
Other1 trial
La Jolla, California1 trial
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
University of California San Diego NAFLD Research Center
Phase 2
Boston, Massachusetts1 trial
Statins to Prevent Cancer Associated Blood Clots
Brigham and Women's Hospital
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.